Compare MFM & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFM | KRMD |
|---|---|---|
| Founded | 1986 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.5M | 192.5M |
| IPO Year | N/A | 2019 |
| Metric | MFM | KRMD |
|---|---|---|
| Price | $4.87 | $3.02 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 471.9K | 226.7K |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.03 | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | N/A | $17.22 |
| P/E Ratio | $162.67 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $4.76 | $2.98 |
| 52 Week High | $5.67 | $6.61 |
| Indicator | MFM | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 24.64 | 24.92 |
| Support Level | N/A | N/A |
| Resistance Level | $5.63 | $3.41 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 25.58 | 3.06 |
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.